journal article·2007-11

Nucleic acid delivery: Where material sciences and bio-sciences meet

Katrien Remaut, Niek N. Sanders, Bruno G. De Geest, Kevin Braeckmans, Jo Demeester, Stefaan C. De Smedt

Publisher page

Abstract

Abstract Advances in biotechnology have led to an accelerated discovery of macromolecular therapeutics such as peptides, proteins and polynucleotides. These macromolecules can be targeted against a variety of diseases, each requiring delivery to a well-defined compartment of the body. As such therapeutics are often prone to degradation before reaching their target site, or do not reach their target site at all, they often require a special formulation. This review focuses on several types of materials that are currently under investigation for the delivery of nucleic acid therapeutics and aims to pinpoint the limitations of these materials with the ultimate goal to identify the material challenges which, in our opinion, will constitute a new generation of ‘intelligent’ materials for nucleic acid delivery. Such ‘intelligent’ materials should be able to sense and respond to environmental changes. The generated response to these environmental changes should give the material new properties that favor the intracellular delivery of their payload. Besides dealing with material properties, we especially aim to focus on the biological barriers such intelligent materials will have to deal with when used for the delivery of nucleic acids. Furthermore, we briefly discuss the advanced light microscopy techniques that are often used to visualize and quantify the steps of the delivery process of nucleic acids.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanowire Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Recent advances with liposomes as pharmaceutical carriers10.1038/nrd1632 ↗
2. Lipofection—a highly efficient, lipid-mediated DNA-transfection procedure10.1073/pnas.84.21.7413 ↗
3. Structure and structure–function studies of lipid/plasmid DNA complexes10.3109/10611860009009206 ↗
4. Cationic lipid structure and formulation considerations for optimal gene transfection of the lung10.3109/10611860009102219 ↗
5. Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency10.1016/j.ymthe.2004.12.018 ↗
6. An inverted hexagonal phase of cationic liposome–DNA complexes related to DNA release and delivery10.1126/science.281.5373.78 ↗
7. Lipoplex formation under equilibrium conditions reveals a three-step mechanism10.1016/S0006-3495(00)76396-X ↗
8. Nanostructure of cationic lipid–oligonucleotide complexes10.1529/biophysj.103.033480 ↗
9. Structure of DNA–cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes10.1126/science.275.5301.810 ↗
10. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy10.1023/A:1020989709019 ↗
11. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides10.1074/jbc.273.25.15621 ↗
12. Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus10.1038/sj.gt.3301663 ↗
13. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides10.1016/j.jconrel.2006.10.029 ↗
14. Cell-specific targeting of lipid-based carriers for ODN and DNA10.1081/LPR-200064961 ↗
15. Current status of polymeric gene delivery systems10.1016/j.addr.2006.03.007 ↗
16. Polymers for gene delivery across length scales10.1038/nmat1645 ↗
17. Synthetic and natural polycations for gene therapy: state of the art and new perspectives10.2174/156652306775515510 ↗
18. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer10.1016/S0169-409X(02)00046-7 ↗
19. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo—polyethylenimine10.1073/pnas.92.16.7297 ↗
20. Poly(ethylenimine) and its role in gene delivery10.1016/S0168-3659(99)00090-5 ↗
21. Polymer side-chain degradation as a tool to control the destabilization of polyplexes10.1023/B:PHAM.0000012165.68765.e6 ↗
22. Cationic polymethacrylates with covalently linked membrane destabilizing peptides as gene delivery vectors10.1016/j.jconrel.2004.06.023 ↗
23. Efficient gene transfer by histidylated polylysine pDNA complexes10.1021/bc9801070 ↗
24. Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA10.1021/ja0015388 ↗
25. Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery10.1021/bc034067y ↗
26. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery10.1002/anie.200351244 ↗
27. Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of degradable polymer library10.1021/ja016288p ↗
28. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes10.1016/j.ejpb.2006.11.009 ↗
29. Block copolymer micelles: preparation, characterization and application in drug delivery10.1016/j.jconrel.2005.09.034 ↗
30. Block copolymer micelles for delivery of gene and related compounds10.1016/S0169-409X(02)00017-0 ↗
31. Poly(-lysine)-g-poly(-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers10.1016/S0168-3659(02)00131-1 ↗
32. Biodegradable polyphosphoester micelles for gene delivery10.1002/jps.20121 ↗
33. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer10.1021/bc9701306 ↗
34. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(l-lysine) block copolymer10.1021/js970304s ↗
35. Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(l-lysine): a potential carrier for systemic delivery of antisense DNA10.1021/bm000142l ↗
36. Release mechanisms for polyelectrolyte capsules10.1039/B600460C ↗
37. Novel hollow polymer shells by colloid-templated assembly of polyelectrolytes10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E ↗
38. Stepwise polyelectrolyte assembly on particle surfaces: a novel approach to colloid design10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q ↗
39. Decomposable hollow biopolymer-based capsules10.1021/bm010052w ↗
40. Probing the permeability of polyelectrolyte multilayer capsules via a molecular beacon approach10.1021/la063674h ↗
41. Intracellularly degradable polyelectrolyte microcapsules10.1002/adma.200502128 ↗
42. Remote activation of capsules containing Ag nanoparticles and IR dye by laser light10.1021/la048873k ↗
43. Degradable polyelectrolyte capsules filled with oligonucleotide sequences10.1002/anie.200602779 ↗
44. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations10.4049/jimmunol.158.10.4529 ↗
45. DNA-based immunization by in vivo transfection of dendritic cells10.1038/nm1096-1122 ↗
46. Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors10.1517/14712598.3.6.903 ↗
47. Microencapsulation of DNA using poly(dl-lactide-co-glycolide): stability issues and release characteristics10.1016/S0168-3659(99)00151-0 ↗
48. Encapsulation of plasmid DNA in biodegradable poly(d,l-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery10.1016/S0168-3659(98)00099-6 ↗
49. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide)10.1038/71916 ↗
50. Controlled DNA delivery systems10.1023/A:1014870102295 ↗
51. Poly(dl-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration10.1016/S0264-410X(96)00266-6 ↗
52. Formulation of poly(d,l-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery10.1016/S0168-3659(99)00275-8 ↗
53. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA10.1016/S0168-3659(01)00397-2 ↗
54. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization10.1021/js9801687 ↗
55. Cationic microparticles: a potent delivery system for DNA vaccines10.1073/pnas.97.2.811 ↗
56. Nanoparticle DNA carrier with poly(l-lysine) grafted polysaccharide copolymer and poly(d,l-lactic acid)10.1021/bc9701048 ↗
57. Cationic stearylamine-containing biodegradable microparticles for DNA delivery10.1080/02652040410001653777 ↗
58. Studies on the potential of microparticles entrapping pDNA-poly(aminoacids) complexes as vaccine delivery systems10.3109/10611860108997934 ↗
59. Preparation and characterization of poly (d,l-lactide-co-glycolide) microspheres for controlled release of poly(l-lysine) complexed plasmid DNA10.1023/A:1018862827426 ↗
60. Long-term release and improved intracellular penetration of oligonucleotide–polyethylenimine complexes entrapped in biodegradable microspheres10.1021/bm025684c ↗
61. Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines10.1073/pnas.0403549101 ↗
62. pH-responsive polymer microspheres: rapid release of encapsulated material within the range of intracellular pH10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.0.CO;2-F ↗
63. Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development10.1021/bc034159n ↗
64. A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels10.1073/pnas.0930644100 ↗
65. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines10.1038/nmat1075 ↗
66. Poly(ortho esters): synthesis, characterization, properties and uses10.1016/S0169-409X(02)00055-8 ↗
67. Transport of molecules in the tumor interstitium—a review
68. Extracellular matrix in renal cell carcinomas
69. Role of tumor–host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors10.1073/pnas.081626898 ↗
70. Transport of molecules, particles, and cells in solid tumors10.1146/annurev.bioeng.1.1.241 ↗
71. Drug delivery and transport to solid tumors10.1023/A:1025785505977 ↗
72. Drug penetration in solid tumours10.1038/nrc1893 ↗
73. In vivo liver-directed gene transfer in rats and pigs with large anionic multilamellar liposomes: routes of administration and effects of surgical manipulations on transfection efficiency10.3109/10611860008997905 ↗
74. Gene therapy for fabry disease10.1023/A:1012455421014 ↗
75. Biological barriers to cellular delivery of lipid-based DNA carriers10.1016/S0169-409X(99)00034-4 ↗
76. Barriers to nonviral gene delivery10.1002/jps.10286 ↗
77. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery10.1038/sj.gt.3302838 ↗
78. Characterization of cationic lipid–protamine–DNA (LPD) complexes for intravenous gene delivery10.1038/sj.gt.3300683 ↗
79. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection10.1038/sj.gt.3300865 ↗
80. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells10.1016/S0005-2760(97)00169-0 ↗
81. Intravenous fate of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes10.1016/j.ejps.2003.09.005 ↗
82. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery10.1038/nbt0297-167 ↗
83. Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum10.1038/sj.gt.3300554 ↗
84. Cationic lipid-mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA10.1023/A:1007425803756 ↗
85. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability10.1002/1521-2254(200011/12)2:6<465::AID-JGM141>3.0.CO;2-Z ↗
86. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin10.1016/S0005-2736(97)00110-7 ↗
87. Two-dimensional condensation of DNA molecules on cationic lipid membranes10.1021/jp962382u ↗
88. PEGylated DNA/transferring–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery10.1038/sj.gt.3300900 ↗
89. Identification of human plasma proteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency: implications for intravenous gene transfer10.1016/S1525-0016(03)00150-3 ↗
90. Lipid mixing between lipoplexes and plasma lipoproteins is a major barrier for intravenous transfection mediated by cationic lipids10.1074/jbc.M414517200 ↗
91. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery10.1089/hum.1996.7.12-1437 ↗
92. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid10.1038/sj.gt.3301460 ↗
93. Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery10.1038/sj.gt.3301705 ↗
94. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration10.1038/sj.gt.3300424 ↗
95. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration10.1089/hum.1998.9.14-2083 ↗
96. Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system10.1016/S0939-6411(01)00165-5 ↗
97. Systemic gene-expression after intravenous DNA delivery into adult mice10.1126/science.7687073 ↗
98. Extravasation of macromolecules10.1016/S0169-409X(98)00006-4 ↗
99. Cellular aspects of trans-capillary exchange10.1152/physrev.1983.63.4.1536 ↗
100. Control of tumour vascular permeability10.1016/S0169-409X(98)00003-9 ↗